ANTIBIOTICS SUSCEPTIBILITY PATTERN OF COAGULASE NEGATIVE STAPHYLOCOCCI ISOLATES FROM ORTHOPAEDIC PATIENTS

Obajuluwa A.F, Onaolapo J.A, Olayinka B.O., Adeshina G.O.

Abstract


A total number of 74 coagulase negative Staphylococci were isolated from orthopaedic patients in Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. They were further characterized into various Staphylococci species using API STAPH identification kit: Staph xylosus (31.1%), Staph lentus (10.8%), Staph hominis (10.8%), Staph cohnii cohnii (5.4%), Staph epidermidis (4.1%) others were Staph cohnii ureal., Staph hyicus, Staph lugdunensis (2.7% each) Staph caprae , Staph capitis, Staph haemolyticus, Staph scuiri, Staph chromogenes and Staph warneri (1.4% each). Microcossus spp was 8.2% while 13.5% isolates were undetermined. Kirby Baurer disk method was used for the antibiotics susceptibility test, the result showed gentamicin and ciprofloxacin to be most active (96.6%), followed by vancomycin (93.1) and pefloxacin (87.9). The isolates were resistant to ampicillin (96.6), amoxicillin clavulanic acid (65.5%), clindamycin 41.4%).

The aim of this study is to classify the coagulase negative Staphylococci isolates into species and to determine their antibiotic susceptibility   

Keywords


coagulase negative Staphylococci, antibiotics, susceptibility.

Full Text:

PDF

References


Chandrasekar P.H and Brown W.J (1994). Clinical issues of blood cultures. Arch Intern Med; 154(8):841-9

Clinical and Laboratory Standards Institute . (2013). Performance standards for antimicrobial susceptibility testing approved standard M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.

Diekema D.J, Pfaller M.A, Schmitz F.J, et al. (2001). Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis; 32 Suppl 2:S114.

Dubois,D.,Leyssene,D.,Chacornac,J.P.,Kostrzewa,M.,Schmit,P.O.,Talon, R., Bonnet, R. & Delmas, J. (2010). Identification of a variety of Staphylococcus species by matrix-assisted laser desorption ionization- time of flight mass spectrometry. J Clin Microbiol 48 , 941–945.

Favre B, Hugonnet S, correa S, Sax H, Rohner P, Pittet D. (2005). Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infect Control Hosp epidemiol;26:697-702.

Hellbacher C, Tornqvist E, Soderquist B. (2006). Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin Microbiol Infect.;12(1):43-9.

Innes A, Burden R.P, Finch R.G, Morgan A.G. (1994). Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial. Nephrol Dial Transplant;9(7):797-9.

John J.F, Harvin A.(2007). History and evolution of antibiotic resistance in coagulase negative staphylococci: susceptibility profiles of new anti-staphylococcal agents. Therapeutics Clin Risk Management. 2007

Kanafani Z.A. (2006). Telavancin: a new lipoglycopeptide with multiple mechanisms of action. Expert Rev Anti Infect Ther.t;4(5):743-9. Review.

Karsten Becker, Christine Heilmann and Georg Peters (2014) Coagulase-Negative Staphylococci. Clin. Microbiol. Rev. ,27(4); 870-926

Levinson, W. (2010). Review of Medical Microbiology and Immunology (11th ed.). pp. 94–99.

Miranda-Novales G, Leanos-Miranda B.E, Vilchis-Perez M, Solorzano-Santos F.(2006). In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains. Ann Clin Microbiol Antimicrob. Oct 12;5:25.

Olsen J.E, Christensen H, Aarestrup F.M. (2006). Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. J Antimicrob Chemother. Mar;57(3):450-60. Epub 2006 Jan 31

Otto, M. (2009). Staphylococcus epidermidis – the ‘accidental pathogen’ Int J Antimicrob Agents 29 (Suppl. 3), S23–S32.

Patterson J.E.(2000). New gram-positive agents in nosocomial infections. Curr. Opin. Infect. Dis. 2000; 13(6): 593-598.

Peters D.H, Clissold S.P. (1992). Clarithromycin: A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs;44:117-64.

Richards M.J, Edwards J.R, Culver D.H, Gaynes R.P.(1999). Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med; 27:887.

Viganego F, Nazir T.M, Lee C.Y, Hafner J.P, Smith R. (2007). Staphylococcus lugdunensis endocarditis following lower extremity revascularization. Int J Cardiol. Mar 2;116(1):e4-6.

Wisplinghoff H, Bischoff T, Tallent S.M, et al.(2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2017 International Educational Applied Scientific Research Journal